| Literature DB >> 26644968 |
Gereltuya Dorj1, Delia Hendrie2, Richard W Parsons3, Bruce Sunderland3.
Abstract
Purpose. The study aimed to determine the extent of and factors influencing the prescribing of injections for the treatment of mild/moderate community acquired pneumonia (CAP) in Mongolia. Methods. Questionnaires were developed and administered to medication providers (34 Pharmacists, 27 pharmacy technicians) and prescribers (22 general doctors and 49 medical specialists) working in Mongolia. Results. Cefalosporins were prescribed for patients with mild pneumonia and doctors tended to prescribe injectable cefalosporins (cefazolin) rather than oral dosage forms. This was supported by the questionnaire study with pharmacists and pharmacy technicians. Additionally, 23 pharmacists and pharmacy technicians indicated that OTC injectable cefalosporins (37.7%) and injectable aminopenicillins (33,9%) were frequently sold by pharmacies for the treatment of mild/moderate CAP. Doctors and particularly pharmacists in the questionnaire studies indicated choosing an injection was to avoid non-compliance problems. Conclusion. High levels of injectable prescribing of antibiotics were found in non-hospitalized patients with CAP in Mongolia. This prevalence level indicated that inappropriate injection prescribing is a public health hazard for Mongolia and requires consideration by the appropriate authorities.Entities:
Keywords: Developing country; Dispensing; Injections; Mongolia; Parenteral medication; Pneumonia; Prescribing
Year: 2015 PMID: 26644968 PMCID: PMC4671187 DOI: 10.7717/peerj.1375
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Demographic characteristics of respondents.
| Variable | Category | Pharmacists and pharmacy technicians ( | Doctors ( | |
|---|---|---|---|---|
| Age (years) | 20–30 | 22 (36.1) | 26 (36.6) | |
| 31–50 | 23 (37.7) | 45 (63.4) | ||
| ≥51 | 16 (26.2) | |||
| Gender | Male | 14 (23.0) | 12 (16.9) | |
| Female | 47 (77.0) | 59 (83.1) | ||
| Practice setting | Owner | Public hospital | 12 (19.7) | 54 (76.1) |
| Employee | Private setting (including FGPs and others) | 49 (80.3) | 17 (23.9) | |
| Professional level | Pharmacist | General doctor | 34 (55.7) | 22 (31.0) |
| Pharmacy technician | Specialist | 27 (44.3) | 49 (69.0) | |
| Years of working experience | 1–5 | 40 (65.6) | 34 (47.9) | |
| 6–10 | 11 (18.0) | 12 (16.9) | ||
| ≥11 | 10 (16.4) | 25 (35.2) | ||
| Monthly income (MNT) | 90.000–200.000 | 9 (15.0) | 12 (17.1) | |
| 201.000–300.000 | 13 (21.7) | 28 (40.0) | ||
| ≥301.000–400.000 | 23 (38.3) | 30 (42.9) | ||
| ≥401.000 | 15 (25.0) |
Notes.
Some responses were missing for each category.
Mongolian National Tugrug, (MNT), currency, 100 USD was equivalent to 130,000 MNT at the time of study.
The number represents respondents aged ≥31 years old.
The number represents respondents with a monthly income of ≥301.000 MNT and higher.
Questionnaire percentage frequencies of antibiotics dispensed with prescription or provided OTC for treatment of CAP, orally and injection by pharmacists and pharmacy technicians (N = 61).
| ATC classification | With prescription | Provided OTC | ||||
|---|---|---|---|---|---|---|
| Never/rarely | Sometimes | Often/always | Never/rarely | Sometimes | Often/always | |
| Aminopenicillins, oral | 77 (31.6) | 70 (28.7) | 97 (39.8) | 79 (32.4) | 73 (29.9) | 92 (37.7) |
| Aminopenicillins, injection | 55 (30.1) | 51 (27.9) | 77 (27.9) | 77 (42.1) | 44 (24.0) | 62 (33.9) |
| Quinolone, oral | 53 (43.4) | 28 (23.0) | 41 (33.6) | 67 (54.9) | 30 (24.6) | 25 (20.5) |
| Quinolone, injection | 13 (21.3) | 14 (23.0) | 34 (55.7) | 30 (49.2) | 13 (21.3) | 18 (29.5) |
| Cefalosporin, oral | 16 (26.2) | 15 (24.6) | 30 (49.2) | 28 (45.9) | 14 (23.0) | 19 (31.1) |
| Cefalosporin, injection | 7 (1.5) | 8 (13.1) | 46 (75.4) | 28 (45.9) | 10 (16.4) | 23 (37.7) |
| Macrolides, oral | 40 (21.9) | 50 (27.3) | 93 (50.8) | 77 (42.1) | 53 (29.0) | 53 (29.0) |
| Macrolides, injection | 131 (71.6) | 26 (14.2) | 26 (14.2) | 134 (73.2) | 29 (15.8) | 20 (10.9) |
| Tetracycline, oral | 103 (84.4) | 16 (13.1) | 3 (2.5) | 91 (74.6) | 19 (15.6) | 12 (9.8) |
| Sulfonamid, oral | 18 (29.5) | 19 (31.1) | 24 (39.3) | 17 (27.9) | 18 (29.5) | 26 (42.6) |
Notes.
Some responses were missing for each category.
Respondents could choose more than option.
Frequencies of non-antibiotic medicines dispensed with prescription and provided OTC for treatment of CAP, by pharmacists and pharmacy technicians (N = 61).
| Other medicines | With prescription | Provided OTC | ||||
|---|---|---|---|---|---|---|
| Never/rarely | Sometimes | Often/always | Never/rarely | Sometimes | Often/always | |
| Corticosteroid, oral | 31 (50.8) | 19 (31.1) | 11 (18.0) | 35 (59.3) | 16 (27.1) | 8 (13.6) |
| Corticosteroid, injection | 19 (31.1) | 24 (39.3) | 18 (29.5) | 28 (48.3) | 24 (41.4) | 6 (10.3) |
| Vitamin, oral | 31 (26.1) | 42 (35.3) | 46 (38.7) | 28 (23.7) | 30 (25.4) | 60 (50.8) |
| Vitamin, injection | 88 (49.4) | 56 (31.5) | 34 (19.1) | 97 (55.1) | 42 (23.9) | 37 (21.0) |
| Antihistamin, oral | 58 (48.7) | 36 (30.3) | 25 (21.0) | 63 (53.4) | 24 (20.3) | 31 (26.3) |
| Antihistamin, injection | 37 (62.7) | 15 (25.4) | 7 (11.9) | 41 (70.7) | 11 (19.0) | 6 (10.3) |
| Xanthin, | 18 (30.0) | 25 (41.7) | 17 (28.3) | 21 (35.0) | 15 (25.0) | 24 (40.0) |
| Xanthin, injection | 27 (45.8) | 19 (32.2) | 13 (22.0) | 34 (57.6) | 12 (20.3) | 13 (22.0) |
| Pyrazolone, oral | 45 (76.3) | 7 (11.9) | 7 (11.9) | 35 (60.3) | 13 (22.4) | 10 (17.2) |
| Pyrazolone, injection | 44 (75.9) | 9 (15.5) | 5 (8.6) | 37 (63.8) | 13 (22.4) | 8 (13.8) |
Notes.
Some responses were missing for each category.
Respondents could choose more than option.
Xanthin is euphyllin.
Percentage frequencies of characteristics that influence the practice of providing medicines and prescribing for the treatment of CAP.
| Characteristic | Pharmacists and pharmacy technicians ( | Doctors ( | ||||
|---|---|---|---|---|---|---|
| D/SD | SA/A | NR | Never/rarely | Sometimes | Often/always | |
| The clinical effect of injections is more potent than oral medicines’ | 14 (24.1) | 40 (68.9) | 4 (6.9) | 16 (22.5) | 24 (33.8) | 31 (43.7) |
| The pharmaceutical quality of injections is better than tablets/capsules | 17 (29.3) | 34 (58.6) | 7 (12.1) | 15 (21.1) | 27 (38.0) | 29 (40.8) |
| Adverse events occur with oral drugs more than with injections | 32 (55.2) | 16 (27.6) | 10 (17.2) | 39 (54.9) | 22 (31.0) | 10 (14.1) |
| The dosage form of injection is chosen for better compliance of a patient | 9 (15.8) | 39 (68.4) | 9 (15.8) | 34 (47.9) | 6 (36.6) | 11 (15.5) |
| The injection requires new syringes and needles | 8 (13.8) | 48 (82.8) | 2 (3.4) | 2 (2.8) | 7 (9.9) | 62 (87.3) |
| Training promotes more about treatment with an injection than oral medicines | 38 (65.5) | 12 (20.7) | 8 (13.8) | 52 (73.2) | 15 (21.1) | 4 (5.6) |
| There is lot of advertisement about injections by drug companies | 38 (65.5) | 11 (19.0) | 9 (15.5) | 35 (49.3) | 27 (38.0) | 9 (12.7) |
| Cost of treatment by oral medicines is more than the treatment cost with injections (including cost of syringes and needles) | 31 (56.9) | 21 (36.2) | 4 (6.9) | 45 (63.4) | 11 (15.5) | 15 (21.1) |
| If patients are prescribed an injection, they are required to visit a pharmacy/hospital several times | 32 (55.1) | 23 (39.7) | 3 (5.2) | 8 (11.2) | 19 (26.8) | 44 (62.0) |
| Patients prefer to use tablets rather than injection | 35 (60.3) | 17 (29.3) | 6 (10.3) | 30 (42.3) | 24 (33.8) | 17 (23.9) |
| When dispensing injections, patient’s age, gender are important | 10 (17.2) | 44 (75.9) | 4 (6.9) | 8 (11.3) | 16 (22.5) | 47 (66.2) |
| Injection is chosen if patient had severe CAP | 10 (17.2) | 46 (79.3) | 2 (3.4) | 16 (22.5) | 21 (29.6) | 34 (47.9) |
Notes.
Strongly agree
Agree
Disagree
Strongly disagree
No response
Some responses were missing for each category.